Strategic Partnering and Investment Support

NCBiotech actively connects North Carolina-based companies and universities with “buy-side” life science entities seeking to strengthen their product pipelines and portfolios. This includes multi-national pharma, biotech, medical device and animal health companies, investors and foundations.

We engage with VCs and technology scouts to understand their investment and partnering interests. We provide them with detailed information on NC-based companies and academic researchers that fit those profiles. We then host private meetings between invited North Carolina companies/researchers and the visiting scouting teams.

To date, we have delivered partnering projects for more than 40 multi-national corporations and prominent investors, which have led to over 200 private meetings. Companies represented include: Abbott Labs, AbbVie, AbbVie Ventures, Boehringer Ingelheim, BI Ventures, Celgene, Daiichi Sankyo, Elanco, Eli Lilly, JDRF, Johnson & Johnson, LabCorp, Lilly Ventures, NCI, Novartis, Novo Nordisk, Pfizer, Sanofi, Sinopharm, ThirdRock Ventures and others.

Partnering at CED Life Science Conference

NCBiotech hosts the partnering program at the annual CED Life Science Conference, connecting regional life science companies with global industry leaders. The 2017 program included 447 participants from 314 organizations, resulting in more than 390 one-on-one partnering meetings.

Celgene
Daiichi Sankyo
Elanco
Johnson and Johnson
LabCorp
Lilly
abbvie
Novartis
Novo Nordisk
Pfizer
Sinopharm